As of Feb 09
| +0.29 / +2.64%|
The 6 analysts offering 12-month price forecasts for Healthways Inc have a median target of 13.00, with a high estimate of 25.00 and a low estimate of 12.00. The median estimate represents a +15.45% increase from the last price of 11.26.
The current consensus among 9 polled investment analysts is to Buy stock in Healthways Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.